Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Buy
28,194
+8,644
+44% +$976K 0.26% 94
2025
Q4
$2.45M Sell
19,550
-1,280
-6% -$163K 0.24% 86
2025
Q3
$2.79M Buy
20,830
+4,056
+24% +$532K 0.61% 40
2025
Q2
$2.28M Buy
16,774
+577
+4% +$76.1K 0.56% 43
2025
Q1
$2.15M Buy
16,197
+83
+0.5% +$10.6K 0.6% 37
2024
Q4
$1.82M Buy
16,114
+225
+1% +$26K 0.53% 41
2024
Q3
$1.81M Sell
15,889
-9
-0.1% -$987 0.54% 40
2024
Q2
$1.65M Buy
15,898
+820
+5% +$86.9K 0.54% 42
2024
Q1
$1.71M Buy
+15,078
New +$1.73M 0.6% 37
2023
Q2
$1.65M Sell
15,156
-145
-0.9% -$15.5K 0.52% 36
2023
Q1
$1.55M Buy
15,301
+9,907
+184% +$1.05M 0.52% 39
2022
Q4
$594K Sell
5,394
-9,614
-64% -$995K 0.35% 55
2022
Q3
$1.45M Buy
+15,008
New +$1.6M 0.91% 29

Other funds holding ABT

Sentinus LLC's ABT Position: Q1 2026 in Review

Sentinus LLC increased its Abbott (ABT) stake by 44% in Q1 2026, buying an estimated $976K and bringing the position to 28,194 shares worth $2.89M. The position accounts for 0.26% of the portfolio, ranked #94.

Sentinus LLC first reported a position in ABT in Q3 2022 and has held it in 13 quarters since. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Sentinus LLC held 28,194 shares of Abbott worth $2.89M as of Q1 2026.
  • Sentinus LLC bought 8,644 Abbott shares in Q1 2026, an estimated $976K.
  • Abbott made up 0.26% of Sentinus LLC's portfolio in Q1 2026, its #94 holding.
  • Sentinus LLC first reported a position in Abbott in Q3 2022 and has held it in 13 quarters since.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.